UnitedHealth Group (UNH) has reported a strong Q1, beating expectations with revenue of $111.7 billion, a 2% year-on-year increase, and an EPS of $7.23, surpassing the anticipated $6.60. The company also raised its full-year EPS guidance from $17.75 to $18.25, well above the Wall Street consensus of $17.80. This positive momentum is bolstered by a decrease in the medical cost ratio to 83.9%, indicating improved profitability amid rising demand for healthcare services in the U.S.
The stock surged nearly 10% in today’s session, reflecting investor confidence as it approaches the upper boundary of its consolidation channel. A breakout above the strong resistance zone of $360 to $380 could signal further gains, aligning with the company’s enhanced profitability metrics and favorable market conditions.
For market professionals, UNH’s turnaround highlights the potential for growth in the healthcare sector, particularly as cost optimization strategies yield improved margins. Monitoring the stock’s performance against resistance levels will be crucial for assessing future investment opportunities.
Source: xtb.com